3-(1-3-benzodioxol-5-yl)-5-(3-bromophenyl)-1h-pyrazole and Body-Weight

3-(1-3-benzodioxol-5-yl)-5-(3-bromophenyl)-1h-pyrazole has been researched along with Body-Weight* in 1 studies

Other Studies

1 other study(ies) available for 3-(1-3-benzodioxol-5-yl)-5-(3-bromophenyl)-1h-pyrazole and Body-Weight

ArticleYear
The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset.
    Acta neuropathologica, 2014, Volume: 127, Issue:5

    Topics: alpha-Synuclein; Animals; Antiparkinson Agents; Benzodioxoles; Body Weight; Disease Progression; Disease-Free Survival; Female; Mice, Transgenic; Parkinsonian Disorders; Pyrazoles; Time Factors

2014